Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Syros Pharmaceuticals News

    5,10 $ +0,59% +0,03 $
    In : 4,7564 € | 25.04.24 22:00:04 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3DT8V
    ISIN: US87184Q2066
    US-Symbol: SYRS
    Typ: Aktie

    Syros Pharmaceuticals News

    02.02.24 - PR Newswire
    Thinking about buying stock in Biofrontera, Snowflake, Syros Pharmaceuticals, Agenus, or Kopin?
    Thinking about buying stock in Biofrontera, Snowflake, Syros Pharmaceuticals, Agenus, or Kopin? PR Newswire
    01.02.24 - PR Newswire
    Thinking about buying stock in Applied UV, Crowdstrike, Syros Pharmaceuticals, Captivision, or Polestar Automotive?
    Thinking about buying stock in Applied UV, Crowdstrike, Syros Pharmaceuticals, Captivision, or Polestar Automotive? PR Newswire
    31.01.24 - PR Newswire
    Thinking about buying stock in Rivian Automotive, Bitdeer Technologies, Syros Pharmaceuticals, Lucid Group, or Ayr Wellness?
    Thinking about buying stock in Rivian Automotive, Bitdeer Technologies, Syros Pharmaceuticals, Lucid Group, or Ayr Wellness? PR Newswire
    02.01.24 - PR Newswire
    Thinking about buying stock in NGM Biopharmaceuticals, Syros Pharmaceuticals, Mereo BioPharma, BTCS Inc, or Sentage Holdings?
    Thinking about buying stock in NGM Biopharmaceuticals, Syros Pharmaceuticals, Mereo BioPharma, BTCS Inc, or Sentage Holdings? PR Newswire
    21.09.22 - PR Newswire
    Thinking about buying stock in RA Medical Systems, FREYR Battery, PBF Energy, Coty, or Syros Pharmaceuticals?
    Thinking about buying stock in RA Medical Systems, FREYR Battery, PBF Energy, Coty, or Syros Pharmaceuticals? PR Newswire
    15.09.22 - PR Newswire
    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syros Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire
    13.09.22 - PR Newswire
    Thinking about buying stock in Syros Pharmaceuticals, American Virtual Cloud Technologies, Spectrum Pharmaceuticals, Rivian Automotive, or Peloton Interactive?
    Thinking about buying stock in Syros Pharmaceuticals, American Virtual Cloud Technologies, Spectrum Pharmaceuticals, Rivian Automotive, or Peloton Interactive? PR Newswire
    27.07.22 - PR Newswire
    TYME TECHNOLOGIES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME
    TYME TECHNOLOGIES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in ...
    20.07.22 - PR Newswire
    SHAREHOLDER ALERT: Weiss Law Reminds SYRS, CNVY, RADA, and SIMO Shareholders About Its Ongoing Investigations
    SHAREHOLDER ALERT: Weiss Law Reminds SYRS, CNVY, RADA, and SIMO Shareholders About Its Ongoing Investigations PR Newswire
    12.07.22 - PR Newswire
    INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, LJPC, FSI, SYRS
    INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, LJPC, FSI, SYRS PR Newswire
    11.07.22 - PR Newswire
    SHAREHOLDER ALERT: Weiss Law Reminds SYRS, CNVY, RADA, and SIMO Shareholders About Its Ongoing Investigations
    SHAREHOLDER ALERT: Weiss Law Reminds SYRS, CNVY, RADA, and SIMO Shareholders About Its Ongoing Investigations PR Newswire
    06.07.22 - PR Newswire
    INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ELSE, STCN, SYRS
    INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ELSE, STCN, SYRS PR Newswire
    05.07.22 - PR Newswire
    SHAREHOLDER ALERT: Weiss Law Investigates Syros Pharmaceuticals, Inc.
    SHAREHOLDER ALERT: Weiss Law Investigates Syros Pharmaceuticals, Inc. PR Newswire
    01.06.21 - PR Newswire
    Thinking about buying stock in AMC, Corbus Pharmaceuticals, Syros Pharmaceuticals, Canaan, or Lineage Cell Therapeutics?
    Thinking about buying stock in AMC, Corbus Pharmaceuticals, Syros Pharmaceuticals, Canaan, or Lineage Cell Therapeutics? PR Newswire
    15.04.21 - PR Newswire
    Thinking about buying stock in Inovio Pharmaceuticals, AMC Entertainment, Citigroup, Syros Pharmaceuticals, or Avinger?
    Thinking about buying stock in Inovio Pharmaceuticals, AMC Entertainment, Citigroup, Syros Pharmaceuticals, or Avinger? PR Newswire
    07.07.20 - PR Newswire
    Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing
    Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing Tessera Therapeutics emerges from three years of stealth operations to ...
    28.05.20 - PR Newswire
    Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
    Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-​Partner and CEO of Cellarity PR Newswire
    19.12.19 - PR Newswire
    Flagship Unveils Newest Pioneering Platform: Ring Therapeutics
    Flagship Unveils Newest Pioneering Platform: Ring Therapeutics New Company Is First to Harness the Human Commensal Virome for the Development of Novel DNA and Gene ...
    02.12.19 - PR Newswire
    Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award
    Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award PR Newswire
    14.11.17 - PR Newswire
    Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team
    Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-​Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran ...

    Newssuche

    Videos

    newspaper
    25.04.24 +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »